China Pharma Statistics Share Statistics China Pharma has 3.26M
shares outstanding. The number of shares has increased by 0.03%
in one year.
Shares Outstanding 3.26M Shares Change (YoY) 0.03% Shares Change (QoQ) 0.01% Owned by Institutions (%) 17.09% Shares Floating 2.34M Failed to Deliver (FTD) Shares 3,248 FTD / Avg. Volume 3.02%
Short Selling Information The latest short interest is 12.06K, so 0.37% of the outstanding
shares have been sold short.
Short Interest 12.06K Short % of Shares Out 0.37% Short % of Float 0.41% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -8.59 and the forward
PE ratio is null.
China Pharma's PEG ratio is
1.25.
PE Ratio -8.59 Forward PE n/a PS Ratio 8.98 Forward PS n/a PB Ratio 5.25 P/FCF Ratio -53.68 PEG Ratio 1.25
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for China Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.65,
with a Debt / Equity ratio of 0.46.
Current Ratio 0.65 Quick Ratio 0.2 Debt / Equity 0.46 Debt / EBITDA -1.83 Debt / FCF -4.74 Interest Coverage -29.77
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $20.22K Profits Per Employee $-21.14K Employee Count 224 Asset Turnover 0.3 Inventory Turnover 2.87
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -32.06% in the
last 52 weeks. The beta is 0.88, so China Pharma's
price volatility has been higher than the market average.
Beta 0.88 52-Week Price Change -32.06% 50-Day Moving Average 1.65 200-Day Moving Average 1.95 Relative Strength Index (RSI) 40.5 Average Volume (20 Days) 107,720
Income Statement In the last 12 months, China Pharma had revenue of 4.53M
and earned -4.74M
in profits. Earnings per share was -0.27.
Revenue 4.53M Gross Profit -1.99M Operating Income -4.59M Net Income -4.74M EBITDA -1.96M EBIT -4.58M Earnings Per Share (EPS) -0.27
Full Income Statement Balance Sheet The company has 626.88K in cash and 3.59M in
debt, giving a net cash position of -2.96M.
Cash & Cash Equivalents 626.88K Total Debt 3.59M Net Cash -2.96M Retained Earnings -44.03M Total Assets 13.77M Working Capital -2.55M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -466.36K
and capital expenditures -291.72K, giving a free cash flow of -758.08K.
Operating Cash Flow -466.36K Capital Expenditures -291.72K Free Cash Flow -758.08K FCF Per Share -0.04
Full Cash Flow Statement Margins Gross margin is -43.84%, with operating and profit margins of -101.32% and -104.58%.
Gross Margin -43.84% Operating Margin -101.32% Pretax Margin -104.58% Profit Margin -104.58% EBITDA Margin -43.37% EBIT Margin -101.32% FCF Margin -16.74%
Dividends & Yields CPHI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for CPHI.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 15, 2025. It was a
backward
split with a ratio of 1:10.
Last Split Date Apr 15, 2025 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -99314.62 Piotroski F-Score 6
